EU :腹腔镜 VS 机器人 哪种方式进行根治性前列腺切除术更好?

2021-08-17 泌尿小王 MedSci原创

根治性前列腺切除术(RP)后尿失禁深深地影响患者生活质量。机器人辅助根治性前列腺切除术(RARP)和腹腔镜RP (LRP)是常用的手术方式,研究显示它们对肿瘤治疗效果无差异,而前者对控尿更好。

根治性前列腺切除术(RP)后一过性或持续性尿失禁深深地影响患者生活质量。目前,机器人辅助根治性前列腺切除术(RARP)由于其放大的视野和高精度,被认为可以提供最佳的肿瘤和功能结果腹腔镜RP (LRP)和RARP哪种方式对患者效果更好仍然缺乏相关研究。

 最近,《欧洲泌尿外科杂志》(EU)发表了一项研究结果显示:LRP与RAPR对肿瘤治疗效果没有差异,但是就术后三个月尿控而言,后者更好一些。

临床设计

手术人员要求

(1)所有外科医生均有RARP和LRP的经验,每一种类型的手术超过150例。

(2)因为大多数德国患者更喜欢在机器人的帮助下进行手术,参与者以3:1的比例被随机分配进行RARP或LRP

(3)在3个月的评估和初步研究结果的提取结束之前,患者对手术方法进行盲法。一旦患者被告知所进行的手术类型,在开放试验的背景下获得患者报告的6个月和12个月的结果。

纳入标准

排除标准

手术方式

(1)根据医生的选择,采用经腹膜或腹膜外入路,并根据D ‘Amico标准对所有中、高危患者进行盆腔淋巴结清扫(PLND)。

(2)所有淋巴结清扫均使用标准化的扩展PLND模板,上缘为髂总动脉。

注:术前神经保留是根据临床标准设计的,在手术过程中根据冰冻切片方案进行修改(有证据表明束侵犯后,在患侧进一步切除束)。根据外科医生的决定和局部术后协议,患者在取出引流管后出院。所有患者均接受盆底训练指导

 

随访安排

患者在入院时、术后1、3、6和12个月评估功能和肿瘤预后,同时在24和36个月收集长期肿瘤预后(前列腺特异性抗原)

 研究的主要指标

(1)拔除尿管后三个月尿失禁恢复情况。(24h内未使用尿垫则认为恢复正常)。

次要指标

(1)术后1,3, 6,12月进行以下的问卷评估

(2)失禁问卷简表咨询(ICIQ-SF)

(3)国际勃起功能指数(IIEF-5)

(3)欧洲癌症研究与治疗组织生活质量调查问卷(EORTC-QLQ)

(4)医院焦虑和抑郁量表(HADS-D)

(5)肿瘤结果定义为术后3、6、12、24和36个月的手术边缘阳性和生化复发。

 结果

总共纳入患者782 人

主要指标

(1)在随访3个月时,54%的RARP患者没有使用衬垫或安全衬垫,LRP患者的比例为46%

次要指标

(2)在双侧神经保留的患者中,机器人辅助的优势更为明显,66%的RARP患者处于稳定控尿状态,而50%的LRP患者处于稳定控尿状态

(3)绝大多数失禁患者报告每天都有少量尿漏,只有9.3%的RARP患者和15%的LRP患者报告中度至大量尿漏。

(4)根据ICIQ-SF,RARP和LRP对术后患者1个月 和3个月尿失禁的主观评价也有统计学差异

(5)EORTCPR-25评估的生活质量在机器人辅助下也得到了更好的保存

 

进一步分析的结果

(1)双侧神经保留患者的控尿比例差异更大(RARP: 66%, LRP:49%;p = 0.005)。

(2)年龄65岁和不保留神经手术不利于控尿:

(3)年龄65岁控尿的HR = 0.69 (0.54-0.86,p = 0.001);

(4)不保留神经控尿的HR = 0.56 (0.43-0.72, p <0.0001);

(5)单侧神经保护(vs双侧神经保护)HR = 0.66 (0.44 0.98),p = 0.038。

 ICIQ-SF评分也反映出,与LRP组患者相比,RARP组患者在3个月时的禁尿结果有改善

 

肿瘤治疗效果

RARP和LRP在早期肿瘤预后方面没有显著差异。

这两种技术都显示比较了阳性边缘的手术效果(19% for RARP and 14% for LRP; p = 0.19) 淋巴结浸润率(RARP为7.8%,LRP为4.8%;p = 0.38

 

性功能方面

(1)在术后3个月,分别有18%和6.7%的接受神经保留(双侧或单侧)RARP和LRP的患者报告勃起足以性交(p = 0.007)。

(2)LRP组的IIEF总和平均比RARP组的IIEF总和降低了1.54分(p = 0.026)。

(3)然而,EORC-PR25调查问卷显示,在3个月时,两种技术在性功能和性活动方面没有显著差异。

(4)保留双侧和单侧神经增强了勃起功能恢复,年龄与性功能恢复呈负相关(2.53)。然而,使用的各种工具对效力恢复的评估并不一致。

 

并发症

LRP组患者的并发症发生率较高,但是没有差异(Clavien-Dindo分级):RARP组87例(15%),LRP组41例(21%)发生任何级别的并发症(p = 0.097)。

结论

与腹腔镜入路相比,RARP术后3个月早期失禁恢复较好。年龄和术中神经保留技术进一步影响失禁恢复。在机器人辅助下勃起功能恢复也得到改善,但围手术期发病率和早期肿瘤预后无明显差异。

参考文献

Stolzenburg J-U, et al. Robotic-assisted Versus Laparoscopic Surgery: Outcomes from the First Multicentre, Randomised, Patient-blinded Controlled Trial in Radical Prostatectomy (LAP-01). Eur Urol (2021), https://doi.org/10.1016/j.eururo.2021.01.030

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1708890, encodeId=b9051e0889052, content=<a href='/topic/show?id=ffca32501e6' target=_blank style='color:#2F92EE;'>#前列腺切除#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32501, encryptionId=ffca32501e6, topicName=前列腺切除)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbe731571573, createdName=1249898am25暂无昵称, createdTime=Fri Jun 10 15:35:16 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1877462, encodeId=763a18e746260, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Wed Oct 06 01:35:16 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276486, encodeId=519412e648656, content=<a href='/topic/show?id=768685612db' target=_blank style='color:#2F92EE;'>#腹腔镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85612, encryptionId=768685612db, topicName=腹腔镜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=xinxin088, createdTime=Thu Aug 19 03:35:16 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1322153, encodeId=127813221537d, content=<a href='/topic/show?id=890c611854e' target=_blank style='color:#2F92EE;'>#机器人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61185, encryptionId=890c611854e, topicName=机器人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Thu Aug 19 03:35:16 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1583319, encodeId=65da15833199c, content=<a href='/topic/show?id=f6e1611840d' target=_blank style='color:#2F92EE;'>#机器#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61184, encryptionId=f6e1611840d, topicName=机器)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13dc16973127, createdName=ms6279672939590805, createdTime=Thu Aug 19 03:35:16 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586247, encodeId=9e47158624ef2, content=<a href='/topic/show?id=38f8622191b' target=_blank style='color:#2F92EE;'>#根治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62219, encryptionId=38f8622191b, topicName=根治)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26d917348678, createdName=jeanqiuqiu, createdTime=Thu Aug 19 03:35:16 CST 2021, time=2021-08-19, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1708890, encodeId=b9051e0889052, content=<a href='/topic/show?id=ffca32501e6' target=_blank style='color:#2F92EE;'>#前列腺切除#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32501, encryptionId=ffca32501e6, topicName=前列腺切除)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbe731571573, createdName=1249898am25暂无昵称, createdTime=Fri Jun 10 15:35:16 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1877462, encodeId=763a18e746260, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Wed Oct 06 01:35:16 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276486, encodeId=519412e648656, content=<a href='/topic/show?id=768685612db' target=_blank style='color:#2F92EE;'>#腹腔镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85612, encryptionId=768685612db, topicName=腹腔镜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=xinxin088, createdTime=Thu Aug 19 03:35:16 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1322153, encodeId=127813221537d, content=<a href='/topic/show?id=890c611854e' target=_blank style='color:#2F92EE;'>#机器人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61185, encryptionId=890c611854e, topicName=机器人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Thu Aug 19 03:35:16 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1583319, encodeId=65da15833199c, content=<a href='/topic/show?id=f6e1611840d' target=_blank style='color:#2F92EE;'>#机器#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61184, encryptionId=f6e1611840d, topicName=机器)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13dc16973127, createdName=ms6279672939590805, createdTime=Thu Aug 19 03:35:16 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586247, encodeId=9e47158624ef2, content=<a href='/topic/show?id=38f8622191b' target=_blank style='color:#2F92EE;'>#根治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62219, encryptionId=38f8622191b, topicName=根治)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26d917348678, createdName=jeanqiuqiu, createdTime=Thu Aug 19 03:35:16 CST 2021, time=2021-08-19, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1708890, encodeId=b9051e0889052, content=<a href='/topic/show?id=ffca32501e6' target=_blank style='color:#2F92EE;'>#前列腺切除#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32501, encryptionId=ffca32501e6, topicName=前列腺切除)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbe731571573, createdName=1249898am25暂无昵称, createdTime=Fri Jun 10 15:35:16 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1877462, encodeId=763a18e746260, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Wed Oct 06 01:35:16 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276486, encodeId=519412e648656, content=<a href='/topic/show?id=768685612db' target=_blank style='color:#2F92EE;'>#腹腔镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85612, encryptionId=768685612db, topicName=腹腔镜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=xinxin088, createdTime=Thu Aug 19 03:35:16 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1322153, encodeId=127813221537d, content=<a href='/topic/show?id=890c611854e' target=_blank style='color:#2F92EE;'>#机器人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61185, encryptionId=890c611854e, topicName=机器人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Thu Aug 19 03:35:16 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1583319, encodeId=65da15833199c, content=<a href='/topic/show?id=f6e1611840d' target=_blank style='color:#2F92EE;'>#机器#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61184, encryptionId=f6e1611840d, topicName=机器)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13dc16973127, createdName=ms6279672939590805, createdTime=Thu Aug 19 03:35:16 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586247, encodeId=9e47158624ef2, content=<a href='/topic/show?id=38f8622191b' target=_blank style='color:#2F92EE;'>#根治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62219, encryptionId=38f8622191b, topicName=根治)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26d917348678, createdName=jeanqiuqiu, createdTime=Thu Aug 19 03:35:16 CST 2021, time=2021-08-19, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1708890, encodeId=b9051e0889052, content=<a href='/topic/show?id=ffca32501e6' target=_blank style='color:#2F92EE;'>#前列腺切除#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32501, encryptionId=ffca32501e6, topicName=前列腺切除)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbe731571573, createdName=1249898am25暂无昵称, createdTime=Fri Jun 10 15:35:16 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1877462, encodeId=763a18e746260, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Wed Oct 06 01:35:16 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276486, encodeId=519412e648656, content=<a href='/topic/show?id=768685612db' target=_blank style='color:#2F92EE;'>#腹腔镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85612, encryptionId=768685612db, topicName=腹腔镜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=xinxin088, createdTime=Thu Aug 19 03:35:16 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1322153, encodeId=127813221537d, content=<a href='/topic/show?id=890c611854e' target=_blank style='color:#2F92EE;'>#机器人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61185, encryptionId=890c611854e, topicName=机器人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Thu Aug 19 03:35:16 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1583319, encodeId=65da15833199c, content=<a href='/topic/show?id=f6e1611840d' target=_blank style='color:#2F92EE;'>#机器#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61184, encryptionId=f6e1611840d, topicName=机器)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13dc16973127, createdName=ms6279672939590805, createdTime=Thu Aug 19 03:35:16 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586247, encodeId=9e47158624ef2, content=<a href='/topic/show?id=38f8622191b' target=_blank style='color:#2F92EE;'>#根治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62219, encryptionId=38f8622191b, topicName=根治)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26d917348678, createdName=jeanqiuqiu, createdTime=Thu Aug 19 03:35:16 CST 2021, time=2021-08-19, status=1, ipAttribution=)]
    2021-08-19 xue8602
  5. [GetPortalCommentsPageByObjectIdResponse(id=1708890, encodeId=b9051e0889052, content=<a href='/topic/show?id=ffca32501e6' target=_blank style='color:#2F92EE;'>#前列腺切除#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32501, encryptionId=ffca32501e6, topicName=前列腺切除)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbe731571573, createdName=1249898am25暂无昵称, createdTime=Fri Jun 10 15:35:16 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1877462, encodeId=763a18e746260, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Wed Oct 06 01:35:16 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276486, encodeId=519412e648656, content=<a href='/topic/show?id=768685612db' target=_blank style='color:#2F92EE;'>#腹腔镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85612, encryptionId=768685612db, topicName=腹腔镜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=xinxin088, createdTime=Thu Aug 19 03:35:16 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1322153, encodeId=127813221537d, content=<a href='/topic/show?id=890c611854e' target=_blank style='color:#2F92EE;'>#机器人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61185, encryptionId=890c611854e, topicName=机器人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Thu Aug 19 03:35:16 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1583319, encodeId=65da15833199c, content=<a href='/topic/show?id=f6e1611840d' target=_blank style='color:#2F92EE;'>#机器#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61184, encryptionId=f6e1611840d, topicName=机器)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13dc16973127, createdName=ms6279672939590805, createdTime=Thu Aug 19 03:35:16 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586247, encodeId=9e47158624ef2, content=<a href='/topic/show?id=38f8622191b' target=_blank style='color:#2F92EE;'>#根治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62219, encryptionId=38f8622191b, topicName=根治)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26d917348678, createdName=jeanqiuqiu, createdTime=Thu Aug 19 03:35:16 CST 2021, time=2021-08-19, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1708890, encodeId=b9051e0889052, content=<a href='/topic/show?id=ffca32501e6' target=_blank style='color:#2F92EE;'>#前列腺切除#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32501, encryptionId=ffca32501e6, topicName=前列腺切除)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbe731571573, createdName=1249898am25暂无昵称, createdTime=Fri Jun 10 15:35:16 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1877462, encodeId=763a18e746260, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Wed Oct 06 01:35:16 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276486, encodeId=519412e648656, content=<a href='/topic/show?id=768685612db' target=_blank style='color:#2F92EE;'>#腹腔镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85612, encryptionId=768685612db, topicName=腹腔镜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=xinxin088, createdTime=Thu Aug 19 03:35:16 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1322153, encodeId=127813221537d, content=<a href='/topic/show?id=890c611854e' target=_blank style='color:#2F92EE;'>#机器人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61185, encryptionId=890c611854e, topicName=机器人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Thu Aug 19 03:35:16 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1583319, encodeId=65da15833199c, content=<a href='/topic/show?id=f6e1611840d' target=_blank style='color:#2F92EE;'>#机器#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61184, encryptionId=f6e1611840d, topicName=机器)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13dc16973127, createdName=ms6279672939590805, createdTime=Thu Aug 19 03:35:16 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586247, encodeId=9e47158624ef2, content=<a href='/topic/show?id=38f8622191b' target=_blank style='color:#2F92EE;'>#根治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62219, encryptionId=38f8622191b, topicName=根治)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26d917348678, createdName=jeanqiuqiu, createdTime=Thu Aug 19 03:35:16 CST 2021, time=2021-08-19, status=1, ipAttribution=)]
    2021-08-19 jeanqiuqiu

相关资讯

J Med Life:全麻术后恶心呕吐怎么用药?

恶心是指呕吐前的一种心理上的不安和不适感,呕吐是指上消化道内容物因胸腹肌收缩而回流至口腔,术后恶心呕吐的治疗费用高。近日,比较氟哌啶醇、甲氧氯普胺、右美托咪定、生姜对腹腔镜术后恶心呕吐的影响,发现四种

合并巨大甲状腺肿瘤患者急诊腹腔镜胆囊切除手术麻醉选择1例

诊疗手段的伤害性特征是医学本身的一个缺陷,而且是很多医生极易忽视的部分。现代麻醉学的发展,有更多的技术、手段供临床选择,为外科手术技术的发展拓展了空间;同时,伴随的创伤和并发症也相应增多。因此,如何选

Anesthesiology :静脉麻醉与吸入性麻醉对老年腹腔镜腹部手术患者术后认知的影响:一项多中心、随机试验

手术后神经认知功能恢复延迟与预后不良有关。大多数手术都需要全身麻醉,其中七氟醚和丙泊酚是最常用的吸入和静脉麻醉剂。作者验证了最初的假设,即在丙泊酚麻醉下进行腹腔镜腹部手术的患者比在七氟醚麻醉下进行腹腔

JAMA Surg:肿瘤外科手术医师技巧与患者预后

研究认为,在复杂的肿瘤外科治疗过程中,术中手术技巧对患者预后的影响是十分明显的,不同外科医生在技术表现上存在显著差异,并与临床和病理结果显著相关。

Gastric Cancer:腹腔镜保留幽门胃切除术是术后胃淤滞的危险因素

保留幽门的胃切除术是位于胃中部的胃癌的一种手术方式,目前已通过腹腔镜方法(LPPG)进行。PPG有时在术后早期病程中伴有关键问题,即胃瘀滞,因此本项研究旨在探究此手术方式是否是导致胃瘀滞的危险因素。

拓展阅读

神经源性膀胱护理实践指南(2017年版)

中国康复医学会(Chinese Association Of Rehabilitation Medicine) · 2017-12-30

2022 EAU指南:男性尿失禁

欧洲泌尿外科学会(EAU,European Association of Urology) · 2022-06-10

中成药治疗慢性前列腺炎临床应用指南(2021年)

《中成药治疗优势病种临床应用指南》标准化项目组 · 2022-05-12

腹腔镜肾上腺切除术安全共识

中国医疗保健国际交流促进会泌尿健康促进分会 · 2022-02-15

2022 EAU指南:女性非神经源性下尿路症状的管理(第1部分)

欧洲泌尿外科学会(EAU,European Association of Urology) · 2022-02-22